With extensive participation from US clinical and public health laboratories, academic institutions, and the private sector, the SPHERES consortium aims to generate information about the virus that will strengthen COVID-19 mitigation strategies.
Learn how to protect therapy and service animals during the COVID-19 pandemic. Follow your local guidance for acceptable business and social practices. Follow CDC's general recommendations for protecting pets from infection, when possible.
CDC works with partners to bring together weekly forecasts for COVID-19 deaths in one place. These forecasts have been developed independently and shared publicly. It is important to bring these forecasts together to help understand how they compare with each other and how much uncertainty there is about what may happen in the upcoming four weeks.
The effects of COVID-19 on the health of racial and ethnic minority groups is still emerging; however, current data suggest a disproportionate burden of illness and death among racial and ethnic minority groups. Studies are underway to understand and potentially reduce the impact of COVID-19 on the health of racial and ethnic minorities.
CDC has guidance for administrators of group homes (GHs) for people with disabilities. GH administrators may consider implementing several strategies to encourage behaviors that reduce the spread of COVID-19.
The following interim guidance may help prevent workplace exposures to acute respiratory illnesses, including COVID-19, in non-healthcare settings. The guidance also provides planning considerations if there are more widespread, community outbreaks of COVID-19.
COVID-19 spreads mainly from person to person through respiratory droplets produced when an infected person coughs, sneezes, or talks. These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs.
Limited information is available to characterize the spectrum of clinical illness, transmission efficiency, and the duration of viral shedding for persons with novel coronavirus disease (COVID-19). This guidance is based on available information about COVID-19 and subject to change as additional information becomes available.
Today the number of people in the United States who have died from COVID-19 surpassed 100,000. Families, friends, coworkers, loved ones and community members are grieving for each person who has been lost to this disease.
CDC has published guidance to support Direct Service Providers (DSPs), including personal care attendants, direct support professionals, paraprofessionals, therapists, and others as they support people with disabilities for COVID-19.
This guidance is intended to inform Direct Service Providers, caregivers, parents, and people with developmental and behavioral disorders on accommodations, modifications, and assistance related to COVID-19 preparation and response.
As communities across the United States take steps to slow the spread of COVID-19 by limiting close contact, people are facing new challenges and questions about how to meet basic household needs, such as buying groceries and medicine, and completing banking activities. The following information provides advice about how to meet these household needs in a safe and healthy manner.
Institutions of higher education (IHE), working together with local health departments, have an important role in slowing the spread of diseases, and protecting vulnerable students, staff, and faculty to help ensure a safe and healthy learning environment.
Across America, states and localities are experiencing different stages of the COVID-19 pandemic. Many state and local officials have determined to begin moving gradually and strategically toward reopening their regions. Today, CDC published guidance to help prevent exposures to COVID-19 in facilities used by communities of faith and to keep their staff and attendees as healthy as possible as they exercise their faith.
Environmental health practitioners and rodent control programs: rodent activity is increasing in some jurisdictions. Rodent control and surveillance are critical for protecting public health during responses to natural disasters and public health emergencies. Learn how to address community-wide rodent activity in your area.
Across America, states and localities are experiencing different phases of the COVID-19 pandemic. Many have chosen to begin moving gradually and strategically toward resuming civic life. To help states, tribes, localities, and territories, as well as businesses and community organizations operate as safely as possible during the COVID-19 pandemic.
Recomendaciones interinas para la prevención y el control de infecciones en la atención de pacientes con enfermedad del coronavirus 2019 (COVID-19) confirmada o personas bajo investigación por COVID 19 en entornos de atención médica.
These infection prevention and control considerations are for healthcare facilities providing obstetric care for pregnant patients with confirmed coronavirus disease (COVID-19) or pregnant persons under investigation (PUI) in inpatient obstetric healthcare settings including obstetrical triage, labor and delivery, recovery and inpatient postpartum settings.
The Department of Health and Human Services (HHS) is delivering $11 billion in new funding to support testing for COVID-19. The Centers for Disease Control and Prevention (CDC) will provide $10.25 billion to states, territories, and local jurisdictions through CDC's existing Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) cooperative agreement.
COVID-19 is a new disease and there is limited information regarding risk factors for severe disease. Based on currently available information and clinical expertise, older adults and people of any age who have serious underlying medical conditions might be at higher risk for severe illness from COVID-19.
Guidance intended to provide key actions that local and state health departments, homelessness service systems, housing authorities, emergency planners, healthcare facilities, and homeless outreach services can take to protect people experiencing homelessness from the spread of COVID-19.
To aid healthcare professionals and hospitals, CDC has developed two checklists that identify key actions that can be taken now to enhance preparedness for potential or confirmed patients with coronavirus disease 2019 (COVID-19).
Most people who get sick with COVID-19 will have only mild illness and should recover at home. Care at home can help stop the spread of COVID-19 and help protect people who are at risk for getting seriously ill from COVID-19.
This interim guidance is intended for organizers and staff responsible for planning mass gatherings or large community events in the United States. A mass gathering is a planned or spontaneous event with a large number of people in attendance that could strain the planning and response resources of the community hosting the event, such as a concert, festival, conference, or sporting event.
Guidance for return to work healthcare personnel (HCP) with confirmed COVID-19, or who have suspected COVID-19 (e.g., developed symptoms of a respiratory infection [e.g., cough, sore throat, shortness of breath, fever] but did not get tested for COVID-19).
Coronavirus Disease (COVID-19) is a disease caused by the newly emerged coronavirus SARS-CoV-2. To prevent further spread of SARS-CoV-2 and to collect information to better understand the virus and its impact on health outcomes, CDC has developed a form that provides a standardized approach to reporting COVID-19 cases (individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19). These data are needed to track the impact of the outbreak and inform public health response.
If you are a close contact of someone with COVID-19 or you are a resident in a community where there is ongoing spread of COVID-19 and develop symptoms of COVID-19, call your healthcare provider and tell them about your symptoms and your exposure.
This document is intended for use by federal, state, local, and tribal jurisdictions in the United States. It should be used in conjunction with existing cooling center operation and management plans, procedures, guidance, resources, and systems.
As part of the risk assessment and public health management of persons with potential COVID-19, public health personnel will typically conduct interviews and assess these individuals for fever or other symptoms of COVID-19.
CDC has become aware that members of the general public are receiving calls appearing to originate from CDC through caller ID, or they are receiving scammer voice mail messages saying the caller is from the Centers for Disease Control and Prevention (CDC). Some calls are requesting donations.
Due to extensive community transmission of COVID -19 in the area, CDC urges residents of New York, New Jersey, and Connecticut to refrain from non-essential domestic travel for 14 days effective immediately.
This interim guidance is to help household members plan for community transmission of coronavirus disease 2019 (COVID-19) in the United States. The Centers for Disease Control and Prevention (CDC) encourages household members to prepare for the possibility of a COVID-19 outbreak in their community.
When we issued the self-quarantining guidance for greater New York City residents leaving this area, it was out of an abundance of caution to help protect U.S. areas with lower levels of COVID-19 spread.
There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical management includes infection prevention and control measures and supportive care, including supplementary oxygen and mechanical ventilatory support when indicated. An array of drugs approved for other indications as well as several investigational drugs are being studied in several hundred clinical trials that are underway across the globe. The purpose of this document is to provide information on two of the approved drugs (chloroquine and hydroxychloroquine) and one of the investigational agents (remdesivir) currently in use in the United States.
Guidance for staff at local and state health departments, infection prevention and control professionals, and healthcare personnel who are coordinating the home care and isolation1 of people with confirmed or suspected COVID-19 infection, including persons under investigation.
Introduction of COVID-19 into a long-term residential care facility in Washington resulted in cases among 81 residents, 34 staff members, and 14 visitors; 23 persons died. Limitations in effective infection control and prevention and staff members working in multiple facilities contributed to intra- and interfacility spread.
This first preliminary description of outcomes among patients with COVID-19 in the United States indicates that fatality was highest in persons aged ≥85, ranging from 10% to 27%, followed by 3% to 11% among persons aged 65-84 years, 1% to 3% among persons aged 55-64 years, <1% among persons aged 20-54 years, and no fatalities among persons aged ≤19 years.
Purpose: This document offers a series of strategies or options to optimize supplies of facemasks in healthcare settings when there is limited supply. It does not address other aspects of pandemic planning; for those, healthcare facilities can refer to COVID-19 preparedness plans.
Purpose: This document offers a series of strategies or options to optimize supplies of eye protection in healthcare settings when there is limited supply. It does not address other aspects of pandemic planning; for those, healthcare facilities can refer to COVID-19 preparedness plans.
Purpose: This document offers a series of strategies or options to optimize supplies of isolation gowns in healthcare settings when there is limited supply. It does not address other aspects of pandemic planning; for those, healthcare facilities can refer to COVID-19 preparedness plans.
Guidance for all first responders, including law enforcement, fire services, emergency medical services, and emergency management officials, who anticipate close contact with persons with confirmed or possible COVID-19 in the course of their work.
JMG Software specializes in advanced custom responsive web design, website application development,
SQL Server and Microsoft Visual Studio running on Windows Server Platforms.
We are located in Columbus near
Cleveland, Akron and Canton Ohio.